LCS3
LCS3 is a reversible and non-competitive synergistic inhibitor of glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) with IC50s of 3.3 μM and 3.8 μM, respectively. LCS3 has antitumour activity, induces apoptosis and can be used in the study of lung adenocarcinoma (LUAD) .
Product Specifications
CAS Number
109844-92-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
266.64
Molecular Formula
C11H7ClN2O4
Notes
Research use only, not for human use.
Receptor
Apoptosis | Glutathione reductase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog